GRO Biosciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 17

GRO Biosciences General Information

Description

Developer of a protein engineering platform designed to improve the development of protein-based therapies for complex diseases. The company offers a biotechnology platform with engineered protein design, non-standard amino acid integration, and therapeutic development capabilities, enabling biotechnology and pharmaceutical organizations to create protein-based therapies with improved stability, immune response control, and biological function.

Contact Information

Website
www.grobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 700 Main Street North
  • Lab Central
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 700 Main Street North
  • Lab Central
  • Cambridge, MA 02139
  • United States
+1 (617)

GRO Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GRO Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private Completed Generating Revenue
11. Later Stage VC (Series B) 19-Jul-2024 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
9. Accelerator/Incubator 01-Sep-2022 Completed Generating Revenue
8. Later Stage VC (Series A) 03-Nov-2021 Completed Generating Revenue
7. Grant 15-Sep-2020 Completed Generating Revenue
6. Seed Round 13-Mar-2019 Completed Generating Revenue
5. Grant 01-Feb-2019 Completed Generating Revenue
4. Seed Round 16-Aug-2017 $2.4M $2.4M Completed Startup
3. Accelerator/Incubator 13-Oct-2016 Completed Startup
To view GRO Biosciences’s complete valuation and funding history, request access »

GRO Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A
Seed-1 7,138,773 $0.000010 8% $0.53 $0.53 1x $0.53 2.46%
Seed 5,165,729 $0.000010 8% $0.46 $0.46 1x $0.46 1.78%
To view GRO Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

GRO Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a protein engineering platform designed to improve the development of protein-based therapies for complex d
Biotechnology
Cambridge, MA
35 As of 2024

New York, NY
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GRO Biosciences Competitors (88)

One of GRO Biosciences’s 88 competitors is MeiraGTx, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MeiraGTx Formerly VC-backed New York, NY
Regenxbio Formerly VC-backed Rockville, MD
Therapure Biopharma Formerly PE-Backed Mississauga, Canada
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Byondis Corporation Nijmegen, Netherlands
You’re viewing 5 of 88 competitors. Get the full list »

GRO Biosciences Patents

GRO Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025076412-A1 Modified polypeptides and methods of making and uses thereof Inactive 04-Oct-2023
WO-2024086738-A2 Compositions and methods of use for inteins Inactive 19-Oct-2022
WO-2024086738-A3 Compositions and methods of use for inteins Inactive 19-Oct-2022
WO-2024039740-A2 Polypeptide compositions containing non-standard glycan stub amino acids and methods of making and uses thereof Inactive 16-Aug-2022
WO-2024039740-A3 Polypeptide compositions containing non-standard glycan stub amino acids and methods of making and uses thereof Inactive 16-Aug-2022 C07K14/70571
To view GRO Biosciences’s complete patent history, request access »

GRO Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GRO Biosciences Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Access Biotechnology Corporate Venture Capital Minority
Atlas Venture Venture Capital Minority
Page One Ventures Venture Capital Minority
Termeer Institute Accelerator/Incubator
The Engine Accelerator/Incubator
You’re viewing 5 of 17 investors. Get the full list »

GRO Biosciences FAQs

  • When was GRO Biosciences founded?

    GRO Biosciences was founded in 2016.

  • Where is GRO Biosciences headquartered?

    GRO Biosciences is headquartered in Cambridge, MA.

  • What is the size of GRO Biosciences?

    GRO Biosciences has 35 total employees.

  • What industry is GRO Biosciences in?

    GRO Biosciences’s primary industry is Biotechnology.

  • Is GRO Biosciences a private or public company?

    GRO Biosciences is a Private company.

  • What is GRO Biosciences’s current revenue?

    The current revenue for GRO Biosciences is .

  • How much funding has GRO Biosciences raised over time?

    GRO Biosciences has raised $91.4M.

  • Who are GRO Biosciences’s investors?

    Access Biotechnology, Atlas Venture, Page One Ventures, Termeer Institute, and The Engine are 5 of 17 investors who have invested in GRO Biosciences.

  • Who are GRO Biosciences’s competitors?

    MeiraGTx, Regenxbio, Therapure Biopharma, Genetix Biotherapeutics, and Byondis are some of the 88 competitors of GRO Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process